Show simple item record

dc.contributor.authorLópez Montanero, Edith Elizabethspa
dc.contributor.authorMoscoso Solórzano, Grace Támaraspa
dc.contributor.authorAlvarado Villa, Geovannyspa
dc.contributor.authorMaldonado Guerrero, Bella Irmaspa
dc.contributor.authorFrías Toral, Evelyn Paolaspa
dc.contributor.authorJiménez Jiménez, Fanny Maribelspa
dc.contributor.authorIglesias Arreaga, Adriana Lissettespa 00:00:00 00:00:00
dc.publisherUniversidad de Cartagenaspa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.rightsRevista Ciencias Biomédicas - 2020spa
dc.subjectInfecciones por citomegalovirusspa
dc.subjectReceptores de trasplantesspa
dc.subjectReacción en cadena de la
dc.titlePrevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo realspa
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.title.translatedPrevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo realeng
dc.relation.citationeditionNúm. 1 , Año 2015spa
dc.relation.referencesJawezt E, Melnick A, Adelberg E. Microbiología médica, 25th ed. México: Mc Graw Hill, 2011. 449 pá
dc.relation.referencesVillasís A, Mosqueda JL. Infecciones en trasplante de médula ósea. RevInvestClin. 2005; 57(2)
dc.relation.referencesGutiérrez J, Cruz L. Estudio de la seroprevalencia de la infección por citomegalovirus a través de la concentración sérica de IgG en un hospital de tercer nivel. RevMexPatolClin. 2008;55(4)
dc.relation.referencesBhadauria D, Sharma RK, Kaul A, Prasad N, Gupta A, Gupta A, et al. Cytomegalovirus disease in renal transplant recipients: a single-center experience. Indian J Microbiol. 2012 Sep;52(3)
dc.relation.referencesSagedal S, Hartmann A, Nordal, K, Osnes K, Leivestad T, Foss A, et al. Impact Of Early Cytomegalovirus Infection And Disease On Long - Term Recipient And Kidney Graft Survival. Kidney Int. 2004;
dc.relation.referencesBriganti E, Russ G, Graeme R, McNeil J, Atkins R, et al. Risk of renal allograft loss from recurrent glomerulonephritis. NEngl J Med. 2002;347(2)
dc.relation.referencesOnuigbo M, Haririan A, Ramos E, Klassen D, Wali R, Drachenberg C. Cytomegalovirus–Induced glomerular vasculopathy in renal allograft: A report of two cases. AJT. 2002;
dc.relation.referencesTomlinson L, Boriskin Y, McPhee I, et al. Acute citomegalovirus infection complicated by collapsing glomerulopathy. NDT. 2003;
dc.relation.referencesFishman J, Rubin R. Medical progress: infection in organ–transplant recipients. NEJM. 1998;338(24):1741-51spa
dc.relation.referencesMurray BM, Brentjens J, Amsterdam D, Holwill S, Rice P. Monitoring and diagnosis of cytomegalovirus infection in renal transplantation. J Am Soc Nephrol. 1997;8(9):1448–
dc.relation.referencesFishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741–
dc.relation.referencesPouteil-Noble C, Ecochard R, Landrivon G, Donia-Maged, A, Tardy JC, Bosshard S,et al. Cytomegalovirus infection-an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation. 1993;55(4):851–
dc.relation.referencesSchroeder R, Michelon T ,Yo F , Bortolotto A, ämmerhirt E, Oliveira J, et al. Cytomegalovirus disease latent and active infection rates during the first trimester after kidney transplantation. Transplant Proc. 2004;36(4):896–
dc.relation.referencesMurray BM, Subramaniam S. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients. Transpl Infect Dis. 2004;6(1):3–
dc.relation.referencesLebranchu Y, Bridoux F, Büchler M, Meur Y, Etienne I, Toupance O, et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Trans. 2002;2:48–
dc.relation.referencesMourad G, Rostaing L, Legendre C, Garrigue V, Thervet E, Durand D. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation. 2004;78(4):584–
dc.relation.referencesNemati E, Eizadi M, Moghani Lankarani M, Kardavani B, Khoddami HR. Cytomegalovirus disease after kidney transplantation: clues to accurate diagnosis. Transplant Proc. 2007;39:987–
dc.relation.referencesNakamura R, Battiwalla M, Solomon S, Follmann D, Chakrabarti S, Cortez K, et al. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant. 2004;10:49–
dc.relation.referencesNichols W, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis. 2002;185:273–
dc.relation.referencesBoeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant. 2003;9:543–
dc.relation.referencesTey SK, Kennedy GA, Cromer D, et al. Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications. PLoS One. 2013 Oct 11;8(10)
dc.relation.referencesXiao HW, Luo Y, Lai XY, Shi M, Tan M. Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes. Bone Marrow Transplant. 2014;
dc.relation.referencesRasheed W, Ghavamzadeh A, Hamladji R, Ben T, Alseraihy A, Abdel F, et al Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey. Hematol Oncol Stem Cell Ther. 2013;6(1):14-9. doi: 10.1016/j.hemonc.2013.04.001. Epub 2013 Apr
dc.relation.referencesBarkam C, Kamal H, Dammann E, Diedrich H , Buchholz S, Eder M , et al. Improving safety of preemptive therapy with oral valganciclovir for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Bone Marrow Res. 2012;2012:874601. Epub 2012 Dec
dc.relation.referencesPergam SA, Xie H, Sandhu R, Pollack M, Smith J, Ilieva , et al. Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients. Biol Blood Marrow Transplant. 2012 Sep;18(9)
dc.relation.referencesYi ES, Kim YJ. Cytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patients.Yonsei Med J. 2012 Mar; 53(2)
dc.relation.referencesFarfán M, Torres J, Vergara A, Donoso G, Alba A, París C, et al. Comparación de las técnicas de reacción de polimerasa en cadena en tiempo real y antigenemia para la detección de citomegalovirus en sangre de niños sometidos a trasplantes. Rev Chil Infect. 2011; 28 (2):
dc.relation.referencesGimeno C, Solano C, Latorre JC, Hernández JC, Clari MA, Remigia MJ, et. al. Quantification of DNA in plasma by an automated real-time PCR assay (Cytomegalovirus PCR Kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol. 2008; 46(10): 3311–
dc.relation.referencesPacheco M, Madero L. Oncología pediátrica. Psioncología. 2003; 0(1)
dc.relation.referencesDíaz A, de la Caridad M, Resik S. Infecciones por citomegalovirus. RevCubana MedGenIntegr. 1998;14(3)

Files in this item

Rev Cienc Biomed-2983.pdf23.45Kbapplication/pdfView/Open

This item appears in the following Collection(s)

Show simple item record

Revista Ciencias Biomédicas - 2020
Except where otherwise noted, this item's license is described as Revista Ciencias Biomédicas - 2020